These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8168990)

  • 1. Interleukin-6 serum levels in patients with gynecological tumors.
    Scambia G; Testa U; Panici PB; Martucci R; Foti E; Petrini M; Amoroso M; Masciullo V; Peschle C; Mancuso S
    Int J Cancer; 1994 May; 57(3):318-23. PubMed ID: 8168990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tumor markers in the management of ovarian, endometrial and cervical cancer.
    Gadducci A; Cosio S; Carpi A; Nicolini A; Genazzani AR
    Biomed Pharmacother; 2004 Jan; 58(1):24-38. PubMed ID: 14739059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
    Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
    Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer.
    Plante M; Rubin SC; Wong GY; Federici MG; Finstad CL; Gastl GA
    Cancer; 1994 Apr; 73(7):1882-8. PubMed ID: 8137215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum evaluation of P53 protein in patients with gynaecological cancer.
    Barbati A; Mariani L; Porpora MG; Anceschi M; Collini P; Lauro V; Cosmi EV
    Anticancer Res; 2000; 20(2A):1033-5. PubMed ID: 10810393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High serum levels of interleukin-6 in endometrial carcinoma are associated with uterine serous papillary histology, a highly aggressive and chemotherapy-resistant variant of endometrial cancer.
    Bellone S; Watts K; Cane' S; Palmieri M; Cannon MJ; Burnett A; Roman JJ; Pecorelli S; Santin AD
    Gynecol Oncol; 2005 Jul; 98(1):92-8. PubMed ID: 15904949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is thrombocytosis a valid indicator of advanced stage and high mortality of gynecological cancer?
    Andersen CL; Eskelund CW; Siersma VD; Felding P; Lind B; Palmblad J; Bjerrum OW; Friis S; Hasselbalch HC; de Fine Olivarius N
    Gynecol Oncol; 2015 Nov; 139(2):312-8. PubMed ID: 26407478
    [No Abstract]   [Full Text] [Related]  

  • 9. Normalization of abnormal plasma amino acid profile-based indexes in patients with gynecological malignant tumors after curative treatment.
    Suzuki Y; Tokinaga-Uchiyama A; Mizushima T; Maruyama Y; Mogami T; Shikata N; Ikeda A; Yamamoto H; Miyagi E
    BMC Cancer; 2018 Oct; 18(1):973. PubMed ID: 30314462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of serum Dkk-3 in patients with gynecological cancer.
    Jiang T; Huang L; Wang S; Zhang S
    J Obstet Gynaecol Res; 2010 Aug; 36(4):769-73. PubMed ID: 20666943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of IL-6, IL-8 and CRP as prognostic factors in epithelial ovarian cancer.
    Dobrzycka B; Mackowiak-Matejczyk B; Terlikowska KM; Kulesza-Bronczyk B; Kinalski M; Terlikowski SJ
    Eur Cytokine Netw; 2013; 24(3):106-13. PubMed ID: 24197277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IL-6 levels in ascitic fluid correlate with reactive thrombocytosis in patients with epithelial ovarian cancer.
    Gastl G; Plante M; Finstad CL; Wong GY; Federici MG; Bander NH; Rubin SC
    Br J Haematol; 1993 Mar; 83(3):433-41. PubMed ID: 8485049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum level of macrophage colony-stimulating factor as a marker for gynecologic malignancies.
    Suzuki M; Ohwada M; Sato I; Nagatomo M
    Oncology; 1995; 52(2):128-33. PubMed ID: 7854772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
    Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
    Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum evaluation of interleukin 6 in ovarian cancer patients.
    Tempfer C; Zeisler H; Sliutz G; Haeusler G; Hanzal E; Kainz C
    Gynecol Oncol; 1997 Jul; 66(1):27-30. PubMed ID: 9234916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer.
    Berek JS; Chung C; Kaldi K; Watson JM; Knox RM; Martínez-Maza O
    Am J Obstet Gynecol; 1991 Apr; 164(4):1038-42; discussion 1042-3. PubMed ID: 2014824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum interleukin-1 receptor antagonist levels in women with gynaecological cancers.
    Fujiwaki R; Hata T; Miyazaki K; Kawamura T; Inada K
    Br J Obstet Gynaecol; 1997 Dec; 104(12):1407-8. PubMed ID: 9422021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-6 levels in uterine malignancies. Preliminary data.
    Ferdeghini M; Gadducci A; Prontera C; Bonuccelli A; Annicchiarico C; Fanucchi A; Facchini V; Bianchi R
    Anticancer Res; 1994; 14(2B):735-7. PubMed ID: 8010733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer].
    Kondera-Anasz Z; Mielczarek-Palacz A; Switała J
    Ginekol Pol; 2003 Sep; 74(9):761-6. PubMed ID: 14674121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.